Peg Filgen Injection
Peg Filgen Injection contains pegfilgrastim, a colony-stimulating factor used to reduce the risk of infection caused by febrile neutropenia in patients receiving chemotherapy.
Overview
Peg Filgen Injection contains pegfilgrastim, a long-acting leukocyte growth factor. It is prescribed to reduce the incidence of infection, manifested by febrile neutropenia, in patients undergoing myelosuppressive chemotherapy for non-myeloid malignancies. You can order Peg Filgen Injection safely from PakMeds with proper temperature-controlled handling.
Key Benefits of Peg Filgen
Helps stimulate the bone marrow to produce new white blood cells.
Reduces the risk of severe infections during chemotherapy treatments.
Decreases the duration of neutropenia associated with myelosuppressive regimens.
Features a extended duration of action requiring fewer administrations than standard filgrastim.
Supports maintaining planned chemotherapy schedules by preventing dose delays due to low blood counts.
Peg Filgen Ingredients and Usage
Peg Filgen Injection contains pegfilgrastim, which belongs to the class of medications known as hematopoietic growth factors or granulocyte colony-stimulating factors (G-CSF). Pegfilgrastim is a pegylated form of recombinant human filgrastim, giving it a longer half-life in the human body.
It is primarily indicated to lower the risk of infection in patients with non-myeloid cancers who are receiving strong chemotherapy drugs that suppress bone marrow function. It is also used to increase survival in patients acutely exposed to myelosuppressive doses of radiation.
How Does Peg Filgen Work?
Pegfilgrastim binds to specific cell surface receptors on hematopoietic cells in the bone marrow. This stimulates the proliferation, differentiation, and maturation of neutrophil precursor cells into functional white blood cells.
By elevating absolute neutrophil counts, the medicine strengthens the immune system's defense mechanisms against bacterial and fungal pathogens while chemotherapy depresses natural blood cell production.
How to Use Peg Filgen
Peg Filgen Injection is administered as a subcutaneous injection given under the skin. It must be administered by or under the direction of a qualified healthcare professional.
It is usually injected at least 24 hours after receiving a dose of cytotoxic chemotherapy. Do not administer it within 14 days before or 24 hours after chemotherapy dosing.
Follow your doctor's exact instructions regarding administration schedules. Do not alter the recommended usage or stop treatment without consulting your physician.
Peg Filgen Side Effects
While Peg Filgen Injection is generally tolerated, it can cause side effects in some individuals. Inform your doctor promptly if you experience any persistent or severe symptoms.
Bone pain
Pain in limbs or extremities
Headache
Generalized body aches
Injection site pain or redness
Nausea
Warnings
Splenic rupture, including fatal cases, can occur; seek immediate medical attention for left upper abdominal or shoulder tip pain.
Acute respiratory distress syndrome (ARDS) may develop; contact your doctor immediately if you experience fever, cough, or difficulty breathing.
Serious allergic reactions including anaphylaxis can happen; seek urgent emergency care if swelling, rash, or dizziness occurs.
Sickle cell crisis may be triggered in patients with underlying sickle cell disorders.
Glomerulonephritis has been reported; report any dark urine or facial swelling to your physician promptly.
Precautions and Who Should Avoid It
Tell your doctor if you have a history of sickle cell disease, kidney problems, or lung conditions.
Inform your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding before starting therapy.
Report any history of severe allergic reactions to pegfilgrastim, filgrastim, or acrylic polymers.
Routine complete blood counts should be monitored regularly by your oncologist during treatment.
Drug and Food Interactions
Avoid administering Peg Filgen Injection within the period from 14 days before to 24 hours after cytotoxic chemotherapy due to increased sensitivity of rapidly dividing myeloid cells.
Lithium may potentiate the release of neutrophils; use caution if co-administered.
Tell your doctor about all prescription drugs, over-the-counter medications, and supplements you are currently taking.
Peg Filgen Storage Conditions
Peg Filgen Injection must be kept refrigerated between 2°C and 8°C in its original outer package to protect it from light. Do not freeze or shake the syringe. Keep this medication strictly out of the reach and sight of children.
Frequently Asked Questions
What is Peg Filgen Injection used for?
Peg Filgen Injection is used to reduce the duration of neutropenia and lower the risk of infection in patients receiving myelosuppressive chemotherapy for cancer.
How is Peg Filgen Injection stored during delivery in Pakistan?
PakMeds maintains strict cold chain management for temperature-sensitive products like Peg Filgen Injection, ensuring it stays refrigerated between 2°C and 8°C during transit.
When should Peg Filgen be given after chemotherapy?
It is generally administered at least 24 hours after chemotherapy. Your oncologist will specify the precise timing for your treatment protocol.
Is bone pain normal after receiving Peg Filgen Injection?
Yes, bone pain and generalized body aches are common side effects because the medicine stimulates bone marrow to produce white blood cells. Discuss pain management options with your doctor.
Customer Reviews
No reviews yet. Be the first to review this product!
Login to write a review
